Recurrent Glioblastoma (RTOG 1205)

Recurrent Glioblastoma (RTOG 1205)

Type/Disease Site:
Glioblastoma
Trial Category:
Neuro
Phase
II
Location(s)
Nebraska Methodist Hospital
Omaha
Nebraska
Contact(s)
Marlene Watson RN
Phone
402-354-5831
Fax
555-555-5559

Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus
Bevacizumab Alone as Treatment for Recurrent Glioblastoma (RTOG 1205)

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members